A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)
暂无分享,去创建一个
H. Hurwitz | D. Niedzwiecki | G. Blobe | M. Morse | J. Clarke | Yingmiao Liu | J. Strickler | H. Uronis | A. Nixon | Christel N. Rushing | L. Howard | C. Arrowood | E. Dropkin | S. Zafar | M. O'Neill | H. Watson | Emily Bolch